Barcelona, Spain

Jorge D Adsara

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1981.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jorge D Adsara: Innovator in Pharmaceutical Compounds

Introduction

Jorge D Adsara is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative compound that serves as an expectorant. His work exemplifies the intersection of science and practical application in medicine.

Latest Patents

Jorge D Adsara holds a patent for S-(3-Methyl-2-butenyl)cysteine, which can also be presented as a pharmaceutically acceptable salt thereof. This compound is designed to be used in various forms, including capsules, dragees, solutions, syrups, or suppositories. His invention aims to provide effective relief as an expectorant, showcasing his commitment to improving health outcomes.

Career Highlights

Throughout his career, Jorge has focused on developing pharmaceutical solutions that address common health issues. His patent reflects his dedication to innovation in the medical field. With a total of 1 patent, he has established himself as a valuable contributor to pharmaceutical research.

Collaborations

Jorge has worked alongside talented individuals such as Silvano Casadio and Jose M Ribalta. Their collaborative efforts have likely enhanced the development and application of his innovative compounds.

Conclusion

Jorge D Adsara's contributions to the pharmaceutical industry highlight the importance of innovation in healthcare. His work on S-(3-Methyl-2-butenyl)cysteine demonstrates his commitment to improving patient care through effective medicinal solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…